ATF4: a Novel Potential Therapeutic Target for Alzheimer’s Disease

Molecular Neurobiology

Volumn 52, Issue 3, 2015, Pages 1765-1770

  Wei, Na ^a   Zhu, Ling Qiang ^a   Liu, Dan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alzheimer s disease; Apoptosis; ATF4; A ; Synapse; Tau

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; AMYLOID BETA PROTEIN; BECLIN 1; BETA SECRETASE 1; BIM PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 34; INITIATION FACTOR 2ALPHA; PROTEIN BAX; PROTEIN BCL 2; TAU PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVIEW; TRANSCRIPTION INITIATION; UPREGULATION; ANIMAL; BRAIN; METABOLISM; NERVE CELL; SYNAPSE;

ACTIVATING TRANSCRIPTION FACTOR 4; ALZHEIMER DISEASE; ANIMALS; BRAIN; HUMANS; NEURONS; SYNAPSES; TAU PROTEINS;

EID: 84942820709     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8970-8     Document Type: Review

References (51)

1. Ohno M (2014) Roles of eIF2alpha kinases in the pathogenesis of Alzheimer’s disease. Front Mol Neurosci 7:22. doi:10.3389/fnmol.2014.00022
2. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13(2):159–170. doi:10.1093/hmg/ddh019
3. Baleriola J, Walker CA, Jean YY, Crary JF, Troy CM, Nagy PL, Hengst U (2014) Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions. Cell 158(5):1159–1172. doi:10.1016/j.cell.2014.07.001
4. Mitsuda T, Hayakawa Y, Itoh M, Ohta K, Nakagawa T (2007) ATF4 regulates gamma-secretase activity during amino acid imbalance. Biochem Biophys Res Commun 352(3):722–727. doi:10.1016/j.bbrc.2006.11.075
5. Chen A, Muzzio IA, Malleret G, Bartsch D, Verbitsky M, Pavlidis P, Yonan AL, Vronskaya S, Grody MB, Cepeda I, Gilliam TC, Kandel ER (2003) Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and C/EBP proteins. Neuron 39(4):655–669. doi:10.1016/S0896-6273(03)00501-4
6. Karin M, Smeal T (1992) Control of transcription factors by signal transduction pathways: the beginning of the end. Trends Biochem Sci 17(10):418–422
7. Hai T, Curran T (1991) Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 88(9):3720–3724
8. Vincent AC, Struhl K (1992) ACR1, a yeast ATF/CREB repressor. Mol Cell Biol 12(12):5394–5405
9. Chan CP, Kok KH, Tang HM, Wong CM, Jin DY (2013) Internal ribosome entry site-mediated translational regulation of ATF4 splice variant in mammalian unfolded protein response. Biochim Biophys Acta 1833(10):2165–2175. doi:10.1016/j.bbamcr.2013.05.002
10. Vattem KM, Wek RC (2004) Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci USA 101(31):11269–11274. doi:10.1073/pnas.0400541101
11. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C, Popko B, Paules R, Stojdl DF, Bell JC, Hettmann T, Leiden JM, Ron D (2003) An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 11(3):619–633
12. Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, Ron D (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6(5):1099–1108
13. Sun X, Liu J, Crary JF, Malagelada C, Sulzer D, Greene LA, Levy OA (2013) ATF4 protects against neuronal death in cellular Parkinson’s disease models by maintaining levels of parkin. J Neurosci 33(6):2398–2407. doi:10.1523/JNEUROSCI. 2292-12.2013
14. Lee GH, Oh HW, Lim HD, Lee W, Chae HJ, Kim HR (2011) 4-Phenylbutyric acid regulates collagen synthesis and secretion induced by high concentrations of glucose in human gingival fibroblasts. Korean J Physiol Pharmacol 15(6):345–351. doi:10.4196/kjpp.2011.15.6.345
15. Cherasse Y, Maurin AC, Chaveroux C, Jousse C, Carraro V, Parry L, Deval C, Chambon C, Fafournoux P, Bruhat A (2007) The p300/CBP-associated factor (PCAF) is a cofactor of ATF4 for amino acid-regulated transcription of CHOP. Nucleic Acids Res 35(17):5954–5965. doi:10.1093/nar/gkm642
16. Ord D, Ord T (2003) Mouse NIPK interacts with ATF4 and affects its transcriptional activity. Exp Cell Res 286(2):308–320
17. Koditz J, Nesper J, Wottawa M, Stiehl DP, Camenisch G, Franke C, Myllyharju J, Wenger RH, Katschinski DM (2007) Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood 110(10):3610–3617. doi:10.1182/blood-2007-06-094441
18. Pons J, Evrard-Todeschi N, Bertho G, Gharbi-Benarous J, Tanchou V, Benarous R, Girault JP (2008) Transfer-NMR and docking studies identify the binding of the peptide derived from activating transcription factor 4 to protein ubiquitin ligase beta-TrCP. competition STD-NMR with beta-catenin. Biochemistry 47(1):14–29. doi:10.1021/bi7014212
19. Ambivero CT, Cilenti L, Zervos AS (2012) ATF4 interacts with Abro1/KIAA0157 scaffold protein and participates in a cytoprotective pathway. Biochim Biophys Acta 1823(12):2149–2156. doi:10.1016/j.bbamcr.2012.08.020
20. Shoval Y, Berissi H, Kimchi A, Pietrokovski S (2011) New modularity of DAP-kinases: alternative splicing of the DRP-1 gene produces a ZIPk-like isoform. PLoS ONE 6(2):e17344. doi:10.1371/journal.pone.0017344
21. Dobreva G, Chahrour M, Dautzenberg M, Chirivella L, Kanzler B, Farinas I, Karsenty G, Grosschedl R (2006) SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125(5):971–986. doi:10.1016/j.cell.2006.05.012
22. St-Arnaud R, Mandic V, Elchaarani B (2010) FIAT, the factor-inhibiting ATF4-mediated transcription, also represses the transcriptional activity of the bZIP factor FRA-1. Ann N Y Acad Sci 1192:338–343. doi:10.1111/j.1749-6632.2009.05211.x
23. Dey S, Savant S, Teske BF, Hatzoglou M, Calkhoven CF, Wek RC (2012) Transcriptional repression of ATF4 gene by CCAAT/enhancer-binding protein beta (C/EBPbeta) differentially regulates integrated stress response. J Biol Chem 287(26):21936–21949. doi:10.1074/jbc.M112.351783
24. He CH, Gong P, Hu B, Stewart D, Choi ME, Choi AM, Alam J (2001) Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J Biol Chem 276(24):20858–20865. doi:10.1074/jbc.M101198200
25. Cho SH, Oh B, Kim HA, Park JH, Lee M (2013) Post-translational regulation of gene expression using the ATF4 oxygen-dependent degradation domain for hypoxia-specific gene therapy. J Drug Target 21(9):830–836. doi:10.3109/1061186X.2013.829073
26. O’Connor T, Sadleir KR, Maus E, Velliquette RA, Zhao J, Cole SL, Eimer WA, Hitt B, Bembinster LA, Lammich S, Lichtenthaler SF, Hebert SS, De Strooper B, Haass C, Bennett DA, Vassar R (2008) Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 60(6):988–1009. doi:10.1016/j.neuron.2008.10.047
27. Devi L, Ohno M (2014) PERK mediates eIF2alpha phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer’s disease. Neurobiol Aging 35(10):2272–2281. doi:10.1016/j.neurobiolaging.2014.04.031
28. Devi L, Ohno M (2013) Deletion of the eIF2alpha kinase GCN2 fails to rescue the memory decline associated with Alzheimer’s disease. PLoS ONE 8(10):e77335. doi:10.1371/journal.pone.0077335
29. Ohta K, Mizuno A, Ueda M, Li S, Suzuki Y, Hida Y, Hayakawa-Yano Y, Itoh M, Ohta E, Kobori M, Nakagawa T (2010) Autophagy impairment stimulates PS1 expression and gamma-secretase activity. Autophagy 6(3):345–352
30. Liao D, Miller EC, Teravskis PJ (2014) Tau acts as a mediator for Alzheimer’s disease-related synaptic deficits. Eur J Neurosci 39(7):1202–1213. doi:10.1111/ejn.12504
31. Medeiros R, Baglietto-Vargas D, LaFerla FM (2011) The role of tau in Alzheimer’s disease and related disorders. CNS Neurosci Ther 17(5):514–524. doi:10.1111/j.1755-5949.2010.00177.x
32. Yoshizawa T, Hinoi E, Jung DY, Kajimura D, Ferron M, Seo J, Graff JM, Kim JK, Karsenty G (2009) The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J Clin Investig 119(9):2807–2817. doi:10.1172/JCI39366
33. Ma Y, Hendershot LM (2003) Delineation of a negative feedback regulatory loop that controls protein translation during endoplasmic reticulum stress. J Biol Chem 278(37):34864–34873. doi:10.1074/jbc.M301107200
34. Clavarino G, Claudio N, Dalet A, Terawaki S, Couderc T, Chasson L, Ceppi M, Schmidt EK, Wenger T, Lecuit M, Gatti E, Pierre P (2012) Protein phosphatase 1 subunit Ppp1r15a/GADD34 regulates cytokine production in polyinosinic:polycytidylic acid-stimulated dendritic cells. Proc Natl Acad Sci USA 109(8):3006–3011. doi:10.1073/pnas.1104491109
35. Donev R, Kolev M, Millet B, Thome J (2009) Neuronal death in Alzheimer’s disease and therapeutic opportunities. J Cell Mol Med 13(11–12):4329–4348. doi:10.1111/j.1582-4934.2009.00889.x
36. Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP (1999) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 5(1):101–106. doi:10.1038/4789
37. Velez-Pardo C, Arroyave ST, Lopera F, Castano AD, Jimenez Del Rio M (2001) Ultrastructure evidence of necrotic neural cell death in familial Alzheimer’s disease brains bearing presenilin-1 E280A mutation. J Alzheimers Dis 3(4):409–415
38. Mines MA, Beurel E, Jope RS (2011) Regulation of cell survival mechanisms in Alzheimer’s disease by glycogen synthase kinase-3. Int J Alzheimers Dis 2011:861072. doi:10.4061/2011/861072
39. Verfaillie T, Rubio N, Garg AD, Bultynck G, Rizzuto R, Decuypere JP, Piette J, Linehan C, Gupta S, Samali A, Agostinis P (2012) PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ 19(11):1880–1891. doi:10.1038/Cdd.2012.74
40. Galehdar Z, Swan P, Fuerth B, Callaghan SM, Park DS, Cregan SP (2010) Neuronal apoptosis induced by endoplasmic reticulum stress is regulated by ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA. J Neurosci 30(50):16938–16948. doi:10.1523/Jneurosci.1598-10
41. Avery J, Etzion S, DeBosch BJ, Jin XH, Lupu TS, Beitinjaneh B, Grand J, Kovacs A, Sambandam N, Muslin AJ (2010) TRB3 function in cardiac endoplasmic reticulum stress. Circ Res 106(9):1516–U1160. doi:10.1161/Circresaha.109.211920
42. B’Chir W, Maurin AC, Carraro V, Averous J, Jousse C, Muranishi Y, Parry L, Stepien G, Fafournoux P, Bruhat A (2013) The eIF2alpha/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res 41(16):7683–7699. doi:10.1093/nar/gkt563
43. Rouschop KMA, van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW, Lambin P, van der Kogel AJ, Koritzinsky M, Wouters BG (2010) The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest 120(1):127–141. doi:10.1172/Jci40027
44. Nah J, Pyo JO, Jung S, Yoo SM, Kam TI, Chang J, Han J, Soo AAS, Onodera T, Jung YK (2013) BECN1/Beclin 1 is recruited into lipid rafts by prion to activate autophagy in response to amyloid beta 42. Autophagy 9(12):2009–2021
45. Selkoe DJ (2002) Alzheimer’s disease is a synaptic failure. Sci 298(5594):789–791. doi:10.1126/science.1074069
46. Bartsch D, Ghirardi M, Skehel PA, Karl KA, Herder SP, Chen M, Bailey CH, Kandel ER (1995) Aplysia CREB2 represses long-term facilitation: relief of repression converts transient facilitation into long-term functional and structural change. Cell 83(6):979–992
47. Jiang Z, Belforte JE, Lu Y, Yabe Y, Pickel J, Smith CB, Je HS, Lu B, Nakazawa K (2010) eIF2alpha Phosphorylation-dependent translation in CA1 pyramidal cells impairs hippocampal memory consolidation without affecting general translation. J Neurosci 30(7):2582–2594. doi:10.1523/JNEUROSCI. 3971-09.2010
48. Song S, Jung YK (2004) Alzheimer’s disease meets the ubiquitin-proteasome system. Trends Mol Med 10(11):565–570. doi:10.1016/j.molmed.2004.09.005
49. Dong C, Upadhya SC, Ding L, Smith TK, Hegde AN (2008) Proteasome inhibition enhances the induction and impairs the maintenance of late-phase long-term potentiation. Learn Mem 15(5):335–347. doi:10.1101/lm.984508
50. Liu J, Pasini S, Shelanski ML, Greene LA (2014) Activating transcription factor 4 (ATF4) modulates post-synaptic development and dendritic spine morphology. Front Cell Neurosci 8
51. Valera E, Dargusch R, Maher PA, Schubert D (2013) Modulation of 5-lipoxygenase in proteotoxicity and Alzheimer’s disease. J Neurosci 33(25):10512–10525. doi:10.1523/Jneurosci.5183-12.2013